George M. O'Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) seeks applications for the George M. O’Brien Urology Cooperative Research Centers Program (U54). This program will foster multi- and interdisciplinary collaboration between basic, translational, and clinical researchers with diverse expertise to address questions of underlying etiology and biological and clinical features of benign genitourinary diseases and disorders within the NIDDK’s mission. In addition, the program will serve as a national resource for the larger urologic research community and provide opportunities for educational enrichment and engagement of investigators in pilot projects that target innovative science and researchers new to urology. All efforts will address the overall goal of improving prevention and clinical management of benign genitourinary disorders through research excellence, enhanced sharing of resources and access to core services, and establishment of a robust research community trained to address the Nation’s biomedical research needs for benign genitourinary diseases and disorders.  


  • Letter of Intent Due Date: October 4, 2020
  • Application Due Date(s): November 4, 2020  

RFA-DK-20-008 Expiration Date November 5, 2020

Agency Website

Eligibility Requirements

The Center Director is required to have an established record of external funding and research accomplishment but is not required to have a background in genitourinary research. The Center Director may not serve concurrently as the Center Director of a NIDDK George M. O'Brien Urology Cooperative Research Center (U54) and as a PD/PI for a NIDDK Urology Exploratory Center (P20). However, current P20 PDs/PIs are eligible to apply for an NIDDK George M. O'Brien Urology Cooperative Research Center (U54) with the expectation that support from the P20 would terminate. upon receipt of the U54 award.  



Amount Description

Application budgets are limited to $1,000,000 in direct costs per year.

The scope of the proposed project should determine the project period. The maximum project period is 5 years.  

    Funding Type





    Medical - Basic Science
    Medical - Clinical Science
    Medical - Translational

    External Deadline

    November 4, 2020